Catalyst Wire Dossier Catalyst Wire Dossier

CD34+ cell therapy

CD34+ cells
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD34+ cell therapy, covering 2018-01-23 to 2018-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Repetitive Intramyocardial CD34+ Cell Therapy in Dilated Cardiomyopathy (REMEDIUM) [Phase 2, Phase 3]

See pricing